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DUSP 1Induction of pro-inﬂammatory response is a crucial cellular process that detects and controls the invading vi-
ruses at early stages of the infection. Along with other innate immunity, this nonspeciﬁc response would ei-
ther clear the invading viruses or allow the adaptive immune system to establish an effective antiviral
response at late stages of the infection. The objective of this study was to characterize cellular mechanisms
exploited by coronavirus infectious bronchitis virus (IBV) to regulate the induction of two pro-inﬂammatory
cytokines, interleukin (IL)-6 and IL-8, at the transcriptional level. The results showed that IBV infection of cul-
tured human and animal cells activated the p38 mitogen-activated protein kinase (MAPK) pathway and in-
duced the expression of IL-6 and IL-8. Meanwhile, IBV has developed a strategy to counteract the induction of
IL-6 and IL-8 by inducing the expression of dual-speciﬁcity phosphatase 1 (DUSP1), a negative regulator of
the p38 MAPK, in order to limit the production of an excessive amount of IL-6 and IL-8 in the infected
cells. As activation of the p38 MAPK pathway and induction of IL-6 and IL-8 may have multiple pathogenic
effects on the whole host as well as on individual infected cells, regulation of the p38 MAPK and DUSP1 feed-
back loop by IBV may modulate the pathogenesis of the virus.rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The innate immune system is the ﬁrst line of host defense against an
invading viral pathogen and the outcome of an infection is dependent
on the ability of host cells to recognize the invading pathogen and acti-
vate appropriate signaling pathways. Cells are equippedwith a group of
proteins known as pathogen recognition receptors (PRRs), which iden-
tify pathogen-associated molecular patterns (PAMPs). Upon stimula-
tion by pathogens, multiple signaling pathways are activated, leading
to the induction of a number of latent transcription factors and the es-
tablishment of an anti-viral state (Sen, 2001). In cells infected with
RNA and DNA viruses, double-stranded RNA (dsRNA) is produced as a
replication intermediate and recognized as PAMPs by three major
types of RNA sensors, dsRNA-dependent protein kinase (PKR), Toll-
like receptor (TLR) 3, and retinoid acid-inducible gene 1 (RIG-I) and
melanoma differentiation-associated gene 5 (Mda5), leading to the in-
duction of type 1 interferon (IFN) and pro-inﬂammatory cytokines
(Garcia et al., 2007; Takeuchi and Akira, 2009). Cytokines produced dur-
ing a viral infection are potent immunomodulatorymolecules that act as
mediators of inﬂammation and the immune response. They are key reg-
ulators in governing host defense against pathogens. Pro-inﬂammatorycytokines such as tumor necrosis factor alpha (TNF-α), IL-6, and IL-
8 are produced early in the infection, triggering the production of Th1 cy-
tokines such as IFN-γ and IL-2 involved in cellular immune responses. In
this report, the cellular mechanisms exploited by coronavirus infectious
bronchitis virus (IBV) to regulate the induction of two pro-inﬂammatory
cytokines, IL-6 and IL-8, at the transcriptional level were studied.
The mitogen-activated protein kinase (MAPK) pathway is one of the
pathways triggered by PAMP–PRR interaction (Symons et al., 2006),
and involved in different cellular processes, including cell proliferation,
programmed cell death, regulation of transcription, mRNA stability, pro-
tein translation and production of pro-inﬂammatory cytokines (Roux
and Blenis, 2004). Of the threeMAPK pathways described inmammalian
cells, the ERKpathway, the JNKpathway, and the p38MAPKpathway, the
ERK pathway is activated bymitogenic and proliferative stimuli, whereas
the JNK andp38MAPKpathways are activatedby environmental stresses.
So far, four p38 isoforms, p38α, p38β, p38γ and p38δ, have been identi-
ﬁed (Nebreda and Porras, 2000). Among them, p38α is the most widely
expressed and best characterized isoform. Evidence available suggests
that p38 MAPK activates a speciﬁc set of transcription factors, resulting
in the production of pro-inﬂammatory cytokines. For example, embryon-
ic stem cells derived from p38αMAPK-null mice showed a reduced IL-6
production in response to chemical stress (Allen et al., 2000).
Negative regulation of MAPK is through dual-speciﬁcity phospha-
tases (DUSPs) by their dephosphorylating activities on both phosphor-
threonine and phosphor-tyrosine residues on the activated MAPKs.
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DUSP1 being the archetype of the family (Lang et al., 2006). In addition
to heat shock and oxidative stress, DUSP1 has been shown to be up-
regulated by other pro-inﬂammatory stress stimuli, such as ultravi-
olet (UV) irradiation, IL-1 and lipopolysaccharide (LPS) (Abraham
and Clark, 2006; Liu et al., 2007). Prolonged activation of p38 MAPK
in DUSP1-deﬁcient macrophages (Chattopadhyay et al., 2006; Zhao
et al., 2005) indicates that p38 MAPK is the target of DUSP1 (Franklin
and Kraft, 1997). In addition, the levels of the pro-inﬂammatory cyto-
kines TNFα and IL-6 and the anti-inﬂammatory cytokine IL-10 were
substantially increased in DUSP1−/− macrophages upon LPS stimula-
tion (Chi et al., 2006; Hammer et al., 2006; Salojin et al., 2006; Zhao
et al., 2006). Up-regulation of DUSP1 by virus infection was also
reported (Abraham and Clark, 2006), indicating a clear physiological
regulatory role of DUSP1 in innate immunity.
IBV is the prototype virus of group 3 coronaviruses in the family of
coronaviridae (Liu et al., 1997). It is an enveloped RNA virus with a
27.6 kb single strandedRNA genomepackedwith the nucleocapsid pro-
tein (Liu et al., 1991; Liu and Inglis, 1991). IBV infection of chickens
causes an acute and highly contagious respiratory disease (Fang et al.,
2007, 2005; Shen et al., 2004). It initially infects the upper respiratory
tract, where it is restricted to the ciliated and mucus-secreting cells
(Raj and Jones, 1997). High virus titers were detected in the nose, tra-
chea, lung, and airsacs (Ambali and Jones, 1990; Hofstad and Yoder,
1966). Following infection of chickens by IBV, interferon was detected
in trachea and lung (Otsuki et al., 1987). Chicken type 1 interferon re-
duced replication of IBV in chicken tracheal organ culture and kidney
cell culture (Pei et al., 2001). Intravenous or oral application of type I in-
terferon delayed the onset of disease in chickens and its severity. In this
study, analysis of the infected cells by Affymetrix microarray, semi-
quantitative RT-PCR and Northern blot revealed the induction of IRF1,
DUSP1, IL-6 and IL-8 at the transcriptional level. Activation of p38
MAPK was found in cells infected with IBV. Furthermore, this study
showed that p38 activity was responsible for the induction of the two
pro-inﬂammatory cytokines IL-6 and IL-8. The p38 MAPK activity was
regulated by IBV-induced up-regulation of DUSP1, resulting in the sup-
pression of excessive induction of the pro-inﬂammatory cytokines.
Results
Affymetrix array analysis of the expression proﬁle of interferon related
genes and other cytokine/chemokine genes in IBV-infected Vero cells
Determination of the global gene expression proﬁles inmock-treated
and IBV-infected Vero cells at 24 h post-infection by Affymetrix array
revealed a 12.25- to 36-fold induction of 57 interferon-related genes
and other cytokine/chemokine genes at the transcriptional level
(Table 1). Among them, a 6.25- and a 5.76-fold induction of IL-6 and
IL-8, respectively, at the transcriptional level, was detected (Table 1). A
4-fold up-regulation of IRF1 was also observed in the same study. Analy-
sis of IBV-infected Vero cells harvested at 24 h post-infection by real-
time RT-PCR showed a 4.5-, 3.8- and 3.2-fold induction of IL-6, IL-8 and
IRF1, respectively, compared to mock-treated cells. Up-regulation of IL-
6 and IL-8 at the protein level in IBV-infected cells, although to a lesser
extent, was also observed in a previous report (Xiao et al., 2008).
Affymetrix array analysis of the global gene expression proﬁles in
mock-treated and IBV-infected Vero cells at 24 h post-infection also
revealed a 4-fold induction of DUSP1 at the transcriptional level in
the infected Vero cells (Table 1).
Northern blot analysis of the induction of IL-6, IL-8, IRF1 and DUSP1 at
the mRNA level in IBV-infected Vero cells
To further conﬁrm the induction of IL-6, IL-8 and IRF1 and to study
the induction kinetics in IBV-infected cells, Northern blot analysis of
IL-6, IL-8 and IRF1 at the mRNA level was carried out in IBV-infectedVero cells in a time-course experiment. Vero cells were infected with
IBV at an MOI of approximately 1 and harvested at 0, 8, 16, and 24 h
post-infection. Total RNAs were extracted and subjected to Northern
blot analysis with DIG-labeled DNA probes for IL-6, IL-8, and IRF1, re-
spectively. IBV RNAs were also detected to indicate the efﬁciency of
viral infection, and GAPDH as a loading control for normalization. As
shown in Fig. 1A, IL-6, IL-8 and IRF1 mRNAs were gradually increased
after 8 h post-infection, and peaked at 24 h post-infection. Quantiﬁca-
tion of the corresponding bands by densitometry showed that IL-6
mRNA was induced 17-fold at 8 h post-infection and continued to in-
crease to 109-fold at 24 h post-infection, IL-8 mRNA was induced 3-
fold at 8 h post-infection and continued to increase to 57-fold at
24 h post-infection, and IRF1 was induced 2-fold at 8 h post-infection
and continued to increase to 8-fold at 24 h post-infection (Fig. 1A). It
was noted that the folds of IL-6 and IL-8 induction obtained by this
approach were much higher than those obtained by Affymetrix and
real-time RT-PCR assays. Nevertheless, these results clearly demon-
strate that IL-6, IL-8, and IRF1 are induced at the mRNA level in
Vero cells infected with IBV.
The induction of DUSP1 in IBV-infected Vero cells was also exam-
ined by Northern blot analysis in a time-course experiment (Fig. 1B),
showing gradual induction of DUSP1 mRNA from 12 h to 24 h post-
infection. Quantiﬁcation by densitometry showed a 7.4- to 18-fold in-
duction from 12 to 24 h post-infection (Fig. 1B). The same mem-
branes were stripped and re-probed for IBV RNA, showing gradually
increased accumulation of IBV mRNA from 12 h post-infection, indi-
cating active replication of IBV in the infected cells (Fig. 1B).
Analysis of the induction kinetics of IL-6, IL-8 and IRF1 in IBV-infected
Vero, H1299 and Huh7 cells
To investigate if the induction of cytokines by IBV infection is re-
stricted to speciﬁc cell type, the induction kinetics of IL-6, IL-8 and
IRF-1 were further analyzed in IBV-infected Vero, H1299 and Huh7
cells by semi-quantitative RT-PCR in detailed time-course experi-
ments. Vero, H1299 and Huh7 cells were individually infected with
IBV and harvested at 0, 8, 12, 16, 20 and 24 h post-infection, respec-
tively. Mock-infected cells harvested at 24 h post-infection were
used as negative controls for each cell line. Semi-quantitative RT-
PCR analysis of IL-6, IL-8 and IRF1 showed that all three factors
were induced with various efﬁciencies at the transcriptional level in
all the three cell lines. Quantiﬁcation of the PCR bands showed that
IL-6 was induced 4- to 5-fold, IL-8 was induced 2- to 12-fold, and
IRF1 was induced 4- to 10-fold over the time-course in IBV-infected
H1299 cells (Fig. 2). In IBV-infected Huh7 cells, IL-6 was induced 2-
to 7-fold, IL-8 was induced 11- to 13-fold, and IRF1 was induced 3-
to 5-fold (Fig. 2). In IBV-infected Vero cells, IL-6 was induced 2- to
6-fold, IL-8 was induced 3- to 7-fold, and IRF1 was induced 5- to
31-fold (Fig. 2). It was noted that minor induction of these cytokines
was also observed in mock-treated cells which might be due to the
serum starvation or cell overgrowth (Fig. 2). After normalization,
the relative induction folds of IL-6 and IL-8 in IBV-infected Vero
cells at 24 h post-infection determined by semi-quantitative RT-PCR
were roughly comparable to those obtained by Affymetrix and real-
time RT-PCR assays. Semi-quantitative RT-PCR was therefore used
to quantify the induction folds of these factors in most experiments
described in the subsequent sections. IBV gRNA(+) was detected
for indication of efﬁcient viral replication, showing gradually in-
creased accumulation of the viral gRNA(+) over time (Fig. 2). These
observations further conﬁrm that IBV infection of cultured cells
from different origins induces the transcription of IL-6, IL-8 and IRF1.
Activation of p38 MAPK and MKK3/6 in IBV-infected cells
Previous studies have demonstrated that p38 MAPK plays an im-
portant regulatory role in the induction of IL-6 by various stimuli,
Table 1
Affymetrix array analysis of the expression proﬁle of interferon-related and cytokine/chemokine genes in IBV-infected Vero cells.
Gene Accession No. Fold induction Description
1. Interferon-related and inducible genes
ISG20 NM_002201.2 36 Interferon stimulated gene (20 kD)
44-kD NM_006417.1 14.44 Interferon-induced, hepatitis C-associated
microtubular aggregate protein
ISG15 NM_005101.1 7.29 Interferon-stimulated protein, 15 kDa
IRF1 NM_002198.1 4 Interferon regulatory factor 1
IFT2 BE888744 3.24 Similar to interferon-induced protein with
tetratricopeptide repeats 2
IFIT4 NM_001549.1 2.56 Interferon-induced protein with
tetratricopeptide repeats 4
IFRD1 NM_001550.1 2.25 Interferon-related developmental regulator 1
ISGF3G NM_006084.1 1.44 Interferon-stimulated transcription factor 3, gamma (48 kD)
GBP2 NM_004120.2 1.21 Guanylate binding protein 2, interferon-inducible
IFRD2 BC001327.1 0.81 Interferon-related developmental regulator 2
1-8U AL031577 0.64 Similar to interferon-inducible protein 1-8U
PKRIR NM_004705.1 0.16 PKR inhibitor, repressor of PKR
IFI30 NM_006332.1 0.04 Interferon, gamma-inducible protein 30
IFI16 NM_005531.1 0.04 Interferon, gamma-inducible protein 16
IRF5 NM_002200.1 0.04 Interferon regulatory factor 5
IRF2 NM_002199.2 −0.01 Interferon regulatory factor 2
9–27 AA749101 −0.01 Interferon induced transmembrane protein 1
IFI16b AF208043.1 −0.01 Interferon, gamma-inducible protein 16
PKR NM_002759.1 −0.04 Protein kinase, interferon-inducible double
stranded RNA dependent
IFI41 NM_004509.1 −0.04 Interferon-induced protein 41, 30 kD
IFNGR1 NM_000416.1 −0.04 Interferon gamma receptor 1
IRF3 NM_001571.1 −0.25 Interferon regulatory factor 3
IFNA5 NM_002169.1 −0.25 Interferon, alpha 5
RAX AF083033.1 −0.36 PKR-associating protein
IFNA16 NM_002173.1 −0.49 Interferon, alpha 16
IFITM2 NM_006435.1 −1 Interferon induced transmembrane protein 2 (1-8D)
IFITM3 AL121994 −1 Similar to interferon induced transmembrane protein 3
2. Other cytokines and chemokines
H174 AF002985.1 23.04 Putative alpha chemokine
SCYA3 NM_002983.1 18.49 Small inducible cytokine A3 (homologous
to mouse Mip-1a)
SCYA7 NM_006273.2 10.89 Small inducible cytokine A7 (monocyte
chemotactic protein 3)
IL12A NM_000882.1 6.25 Interleukin 12A)
IL6 NM_000600.1 6.25 Interleukin 6
IL8 AF043337.1 5.76 Interleukin 8 C-terminal variant
NFIL3 NM_005384.1 4.84 Nuclear factor, interleukin 3 regulated
IL1A M15329.1 2.56 Interleukin 1-alpha
SCYB10 NM_001565.1 1.96 Small inducible cytokine subfamily B
(Cys-×-Cys), member 10
IL15 NM_000585.1 1.44 Interleukin 15
TCF8 NM_030751.1 0.64 Transcription factor 8 (represses interleukin 2 expression)
ILF3 NM_004516.1 0.36 Interleukin enhancer binding factor 3, 90 kD
Fusin AJ224869 0.36 Consensus includes chemokine (C-×-C motif), receptor 4
ILF1 NM_004514.1 0.25 Interleukin enhancer binding factor 1
SCYE1 NM_004757.1 0.25 Small inducible cytokine subfamily E, member
1 (endothelial monocyte-activating)
SCYB6 NM_002993.1 0.25 Small inducible cytokine subfamily B
(Cys-×-Cys), member 6
ILF2 NM_004515.1 0.09 Interleukin enhancer binding factor 2, 45 kD
CREME9 NM_015986.1 0.04 Cytokine receptor-like molecule 9
IL11 NM_000641.1 0.01 Interleukin 11
IL12B NM_002187.1 −0.09 Interleukin 12B
TNFRSF9 NM_001561.2 −0.16 Tumor necrosis factor receptor superfamily, member 9
WSX-1 NM_004843.1 −0.16 Class I cytokine receptor
IL11RA NM_004512.1 −0.25 Interleukin 11 receptor, alpha
CCR9 AF145439.1 −0.36 CC chemokine receptor 9A, alternatively spliced
IL18 NM_001562.1 −1 Interleukin 18 (interferon-gamma-inducing factor)
IL13RA1 NM_001560.1 −1.44 Interleukin 13 receptor, alpha 1
IL7 NM_000880.1 −2.56 Interleukin 7
CRLF1 NM_004750.1 −4.41 Cytokine receptor-like factor 1
SCYB14 NM_004887.1 −12.25 Small inducible cytokine subfamily B
(Cys-×-Cys), member 14
108 Y. Liao et al. / Virology 420 (2011) 106–116such as TNFα (Beyaert et al., 1996), IL-1β (Krause et al., 1998) and
adenosine (Rees et al., 2003), and in IL-8 induction by ribotoxin deox-
ynivalenol in human monocytes (Islam et al., 2006). The effect of IBV
infection on the activation of the p38 MAPK pathway was examined.Vero and H1299 cells infected with live (IBV) or UV-inactivated IBV
(UV-IBV) were harvested at 0, 4, 8, 12, 16, and 20 h post-infection, re-
spectively. UV-IBV was included in the experiment to check whether
virus entry was sufﬁcient to activate this pathway. The p-p38 MAPK
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Fig. 1. Up-regulation of IL-6, IL-8, IRF1 and DUSP1 at the mRNA level in IBV-infected human and animal cell lines. (A) Northern blot analysis of IL-6, IL-8 and IRF1 in IBV-infected
Vero cells. Vero cells were infected with IBV at an MOI of approximately 1 and harvested at 0, 8, 16, and 24 h post-infection, respectively. Total RNAs were extracted, an equal
amount of RNA was separated on agarose gel and subjected to Northern blot with speciﬁc DIG-labeled DNA probes for IL-6, IL-8, IRF1 and IBV gRNA(+). GAPDH was used as an
internal control. The intensity of each band was determined by densitometry, and was shown as fold induction after normalization to GAPDH. The signal for each mRNA species
at 0 h post-infection was treated as 1. (B) Up-regulation of DUSP1 in IBV infected Vero cells. Cells were infected with IBV, harvested at 0, 8, 12, 16, 20, and 24 h post-infection, re-
spectively. Total RNA was extracted, an equal amount of total RNA was resolved on agarose gel and Northern blot was performed to detect DUSP1, IBV gRNA(+), and GAPDH using
speciﬁc DIG-labeled DNA probes. The intensities of DUSP1 in IBV-infected Vero (DUSP1) were determined by densitometry, and were shown as fold induction after normalization to
GAPDH. The signal at 0 h post-infection was treated as 1.
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MAPK was detected by p38 MAPK antibody in the same membrane
after stripping off p-p38 antibody. Result showed that p-p38 MAPK
was increased from 12 h to 24 h post-infection and the total p38
MAPK expression was relatively over the time-course (Fig. 3A).
After normalization of p-p38MAPK to p38 MAPK, a 2.2- to 2.7-fold in-
crease of p-p38 MAPK was observed from 12 to 20 h post-infection in
IBV-infected Vero cells; a 2.1- to 2.5-fold induction of p-p38 was
detected from 12 to 20 h post-infection in IBV-infected H1299 cells;
and a 3- to 4-fold induction of p-p38 was also detected at 16 and
20 h post-infection in IBV-infected Huh7 cells (Fig. 3A). However, in
cells infected with UV-IBV, the p-p38 MAPK level was relatively con-
stant over the time-course (Fig. 3A), suggesting that the virus entry
step is not sufﬁcient to activate this pathway. The same membranesH1299 Huh7
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Fig. 2. Analysis of the induction kinetics of IL-6, IL-8 and IRF1 in IBV-infected H1299,
Huh-7 and Vero cells by semi-quantitative RT-PCR. Cells were either infected with
IBV or mock-infected for 24 h (M) as a control. The infected cells were harvested at
0, 8, 12, 16, 20, and 24 h post-infection, respectively, and subjected to RNA extraction.
Semi-quantitative RT-PCR was performed using appropriate sets of primers to detect
IL-6, IL-8, IRF1, IBV gRNA(+) and GAPDH. The intensity of each band was determined
by densitometry, and was shown as fold induction after normalization to GAPDH. The
signal for each mRNA species at 0 h post-infection was treated as 1.were stripped and re-probed with IBV M or N protein antibodies,
showed the efﬁcient virus replication in IBV-infected cells. β-tubulin
was probed as an internal loading control (Fig. 3A). These results
demonstrate that p38 MAPK was activated in IBV-infected cells and
active virus replication is required for this activation. As phosphoryla-
tion of p38 MAPK was observed in all three cell lines, it also suggests
that activation of the p38 MAPK pathway upon IBV infection is not re-
stricted to a speciﬁc cell type.
Since activation of p38 MAPK pathway was initiated by MAPK kinase
3/6 (MKK 3/6) (Goh et al., 2000), the MKK3/6 phosphorylation was then
examined by Western blot in IBV-infected H1299 cells in a time-course
experiment. PVDF membrane was probed with p-MKK3/6 antibody
ﬁrst and reprobed with total MKK3 antibody after stripping off the p-
MKK3/6 antibody. As shown in Fig. 3B, the total levels of MKK3 kept in
stable amount during the time-course and the levels of p-pMKK3/6 in-
creased in IBV-infected cells. After normalization of p-MKK3/6- to total
MKK3, the increased levels of p-MKK3/6 were quantiﬁed as 1.8-, 2.1-
and 2.5-fold at 12, 15 and 18 h post-infection, respectively, in IBV infected
cells, but only increased 1.1- to 1.2-fold in cells infected with UV-IBV
(Fig. 3B). It suggests that MKK3/6 is activated upon IBV infection and
virus replication is required for this activation.
Inhibition of the IL-6 and IL-8 induction in IBV-infected cells in the pres-
ence of p38 MAPK inhibitor SB203580
To establish the relationship between the p38 MAPK activation and
the induction of IL-6 and IL-8 in cells infected with IBV, SB203580, a
p38 MAPK inhibitor, was added to the infected cells and its effect on
IBV-induced IL-6 and IL-8 up-regulationwas analyzed. SB203580 inhibits
the p38 MAPK activity by blocking its catalytic function but not phos-
phorylation, resulting in the suppression of the downstream substrate ac-
tivation in the p38MAPKpathway (Kumar et al., 1999). H1299 cells were
either treated with 50 μM of SB203580 or mock-treated with DMSO
alone for 1 h prior to IBV infection and throughout the time-course. At
different time points post-infection, cells were lysed and subjected to
Western blot with antibodies against p-p38, p38, IBV N protein and
actin. As shown in Fig. 4A, similar amounts of IBVNproteinwere detected
in SB203580- and DMSO-treated cells at each time point. Elevated levels
of p-p38 MAPK were observed in both SB203580- and DMSO-treated
samples from 8 h post-infection until 16 h post-infection, although
BA
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Fig. 3. Activation of p38 MAPK and MKK3/6 in IBV-infected cells. (A) Activation of p38 MAPK in IBV-infected Vero, H1299 and Huh7 cells. Cells were infected with live IBV or UV-IBV
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4, 8, 12 and 16 h post-infection (Fig. 4A). At 20 h post-infection, the level
of p-p38 MAPK was slightly reduced in SB203580-treated cells (Fig. 4A).
The increased detection of p-p38 MAPK in cells treated with SB203580
was also observed in IBV-infected Vero cells at 8 h post-infection
(Fig. 4B), and was reported in other studies (Ciufﬁni et al., 2008). Similar
levels of IBV M protein were detected in SB203580- and DMSO-treated
cells at 8 h and 20 h post-infection (Fig. 4B).
The induction of IL-6 and IL-8 at the mRNA level in the presence of
SB203580 was then analyzed by Northern blot in IBV infected Vero
cells harvested at 20 h post-infection. As shown in Fig. 4C, the pres-
ence of SB203580 in the infected cells greatly suppressed IBV-induced
IL-6 and IL-8 transcription, while DMSO alone had much less effect on
IL-6 and IL-8 induction. These results demonstrate that SB203580
blocks the p38 MAPK activity and reduces IL-6 and IL-8 induction in
IBV-infected cells, indicating that the p38 MAPK pathway is involved
in the induction of IL-6 and IL-8.
Regulation of IL-6 and IL-8 induction in IBV-infected cells by manipula-
tion of the p38 MAPK expression
To further conﬁrm that the induction of IL-6 and IL-8 by IBV infection
is through the p38 MAPK pathway, siRNA-mediated knockdown of p38
MAPK was performed by transiently expressing siRNA targeting p38
MAPK in H1299 cells followed by IBV infection in a time-course manner.
Negative control siRNAwas transfected into another set of cells as a con-
trol. The p38 MAPK knockdown efﬁciency was conﬁrmed by semi-quantitative RT-PCR andWestern blot, showing an almost 100% knock-
down efﬁciency at the mRNA level and 18–62% knockdown efﬁciencies
at the protein level at different timepoints (Fig. 5A). Examination of IL-6
and IL-8 at themRNA level by semi-quantitative RT-PCR revealed signif-
icant induction in cells transfectedwith the negative control siRNA over
the time-course (Fig. 5A). However, in p38-knockdown cells, the induc-
tion of IL-6 and IL-8 was progressively suppressed from 12 to 15 h post-
infection, and reduced to aminimal level at 18 h post-infection (Fig. 5A),
conﬁrming that p38MAPK pathway is important for IL-6 and IL-8 induc-
tion. Similar levels of viral RNA were detected by semi-quantitative RT-
PCR in both p38-knockdown and control cells (Fig. 5A). However, at
the protein level, less IBV S protein was detected in the knockdown
cells infected with IBV at 12 h post-infection, compared to that in the
control cells (Fig. 5A). The difference became much smaller, but was
still discernable, at later time points (Fig. 5A), suggesting that the p38
MAPK may also be involved in regulation of the viral replication cycle.
The effects of p38 MAPK on IBV-induced IL-6 up-regulation and
viral replication cycle were further tested by infection of wild type
MEFs (WT) and a non-functional p38 knock-in MEF cell line (p38
KI) (Shreeram et al., 2006) with IBV. As shown in Fig. 5B, detection
of both sense and anti-sense strands of IBV gRNAs showed an inhibi-
tion of virus replication in p38 KI cells compared to WT cells, with an
approximately 10-fold reduction in the production of both positive-
and negative-strand gRNAs at 18 h post-infection. The expression of
IBV N protein and total p38 MAPK was conﬁrmed by Western blot.
Quantiﬁcation by densitometry indicated a 5-fold reduction in IBV N
protein synthesis in p38 KI cells compared to WT MEFs after
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was impaired in p38-deﬁciency cells. Determination of the level of IL-
6 mRNA by semi-quantitative RT-PCR revealed an approximately 5-
fold reduction in p38 KI cells (Fig. 5B). Taken together, these data fur-
ther conﬁrm that IBV infection enhances IL-6 and IL-8 transcription
through the p38 MAPK pathway and a functional p38 MAPK pathway
is beneﬁcial to virus replication.
The effects of DUSP1 up-regulation on the activation of p38 MAPK and
the induction of IL-6 and IL-8 in IBV-infected cells
To investigate the induction kinetics and the role of DUSP1 in p38
MAPK pathway activation and IL-6 and IL-8 up-regulation in IBV-
infected cells, we checked the p38 MAPK activity and IL-6 induction
by blocking DUSP1 function in IBV-infected H1299 cells. First, we con-
ﬁrmed the induction of DUSP1 in IBV-infected H1299 cells which was
conﬁrmed by Northern blot analysis in a time-course experiment
(Fig. 6A). Similar to IBV-infected Vero cells (Fig. 1B), gradual induc-
tion of DUSP1 mRNA from 12 h to 24 h post-infection was observed
in IBV-infected H1299 cells (Fig. 6A). Quantiﬁcation by densitometry
showed a 5.7- to 11-fold induction during the time-course. Re-probing
of the samemembranes for IBV RNA showed gradually increased accu-
mulation of IBVmRNA from 12 h post-infection, indicating active repli-
cation of IBV in the infected cells (Fig. 6A).
The regulatory role of DUSP1 in the activation of the p38 MAPK
pathway and in IL-6 and IL-8 induction was then investigated by addi-
tion of Ro-31-8200 (Ro), a DUSP1 speciﬁc inhibitor, to H1299 cells 1 h
prior to IBV infection in a time-course manner. DMSOwas added to an-
other set of cells as negative control. The inhibitory effect of Ro on the
DUSP1 phosphatase activity was conﬁrmed by detection of p-p38MAPK level by Western blot (Fig. 6B). Compared to the DMSO-treated
cells, a 1.2- to 3.5-fold increase of p-p38 was detected in Ro-treated
cells at 12 h, 18 h, and 24 h post-infection, indicating that the DUSP1 ac-
tivity was efﬁciently blocked by Ro. Western blot analysis of the total
p38 showed treatment of cells with the inhibitor did not affect the over-
all level of the protein (Fig. 6B). More induction of IL-6 at each time
point post-infection was detected in cells treated with the inhibitor,
compared to that in the DMSO-treated cells (Fig. 6B), indicating that in-
hibition of DUSP1 resulted inmore activation of p38 pathway and an in-
crease of the IL-6 production. Detection of the positive-strand viral
gRNA(+) showed a similar level of viral infection in cells treated with
and without the inhibitor (Fig. 6B).
The regulatory role of DUSP1 in IL-6 and IL-8 induction in IBV-
infected cells was further investigated by knockdown of DUSP1.
DUSP1 iRNA and non-targeting control siRNA were transiently trans-
fected in two groups of H1299 cells followed by IBV infection in a
time-course manner. As shown by semi-quantitative RT-PCR, 24–73%
DUSP1-knockdown efﬁciencies were achieved at the mRNA level and
IBV infection was minimally affected by detection of viral gRNA(+)
(Fig. 6C). As expected, induction of IL-6 and IL-8 was generally at a
higher level (1.5- to 3.21-fold increase for IL-6 and 1.11- to 3.1-fold in-
crease for IL-8) in DUSP1-knockdown cells than that in the control cells
at each time point. These results collectively suggest that DUSP1 may
negatively regulate the induction of IL-6 and IL-8 at late stages of virus
infection.
Discussion
Invasion of cells by pathogens activates the host innate immune
response, including the induction of pro-inﬂammatory cytokines
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mokines plays an important role in the pathogenesis of virus infec-
tion, and may be regulated by the p38 MAPK and DUSP1 feedback
loop. The p38 MAPK is involved in numerous biological processes, in-
cluding apoptosis, cell proliferation, and cytokine production. On the
other hand, DUSP1 negatively regulates p38 MAPK phosphorylation
and forms a feedback loop. In this study, we show that levels of two
pro-inﬂammatory cytokines, IL-6 and IL-8, were greatly elevated dur-
ing IBV infection of cultured cells. This induction may be resulted
from activation of the p38 MAPK pathway. Meanwhile, DUSP1 was
also stimulated to regulate the p38 MAPK activity in the late stage
of viral infection. As activation of the p38 MAPK pathway and induc-
tion of IL-6 and IL-8 may have multiple pathogenic effects on the
whole host as well as on individual infected cells, regulation of the
p38 MAPK and DUSP1 feedback loop by IBV may modulate the path-
ogenesis of the virus. Further studies using avian cells, chicken em-
bryos and young chicks would reveal more information on the
functional roles of this regulatory loop in IBV–host interactions, viral
replication and pathogenesis.
The observation that p38 MAPK is activated in IBV-infected cells is
consistent with studies in cells infected with some other coronaviruses.
For example, MHV, a prototype coronavirus in group II, was able to ac-
tivate the p38 MAPK pathway in the infected cells (Banerjee et al.,
2002). Pro-inﬂammatory cytokines, such as TNFα and IL-6, were signif-
icantly induced by infection of primary mouse astrocytes and microglia
with MHV strains JHM and A59 (Yu and Zhang, 2006). It was also ob-
served that phosphorylation of p38 MAPK was greatly elevated in
SARS-CoV-infected Vero E6 cells at 18 h post-infection (Mizutani et
al., 2004). In this study, treatment of cells either with the p38 MAPK-
speciﬁc inhibitor, SB203580, or with a small interfering RNA targeting
p38 MAPK almost abolished the IBV-medicated induction of IL-6 and
IL-8. It was previously suggested that in MHV-infected cells, phosphor-
ylation of eIF4E promoted by p38 MAPK may contribute to theinduction of IL-6 (Banerjee et al., 2002). However, our preliminary
data did not show an increase in the phosphorylation of eIF4E in IBV-
infected cells (data not shown). Based on the observation that IL-6 in-
duction was detected at the transcriptional level in IBV-infected cells,
it is unlikely that eIF4E phosphorylation is a major contributing factor
in IL-6 induction by IBV infection.
In addition to its involvement in the induction of IL-6 and IL-8, p38
MAPK has been shown to play a role in promotion of both cell death
and survival (Dent et al., 2003). In a previous study, caspase-dependent
apoptosis was found to be induced in IBV-infected cells at late stages of
the infection cycle (Liu et al., 2001), suggesting that a balance between
cell survival and apoptosis may be achieved in the IBV-infected cells.
Further studies would be required to illustrate the functional signiﬁ-
cance of p38 MAPK activation in the virus–host interactions and patho-
genesis of IBV.
In this study, up-regulation of DUSP1 was observed in IBV-infected
cells. DUSP1 is known to be a negative regulator in the innate immune
system. It is a protein phosphatase that regulates the activities of p38
MAPK and JNK, and, to a less extent, the ERK1/2 MAPK activity. It func-
tions as a negative regulator to suppress the production of excessive cy-
tokines and inﬂammatory responses (Turpeinen et al.). In DUSP1-
deﬁcient mice, increased levels of IL-6 and other cytokines were
detected (Hammer et al., 2006). Up-regulation of DUSP1 was detected
in cells in response to pro-inﬂammatory stress stimuli, such as UV irra-
diation and treatment of cells with pro-inﬂammatory cytokine IL-1
(Lasa et al., 2002; Li et al., 2001; Toh et al., 2004). Up-regulation of
DUSP1 upon infections by viruses was also reported (Abraham and
Clark, 2006). One example is the nef protein of human immunodeﬁcien-
cy virus (HIV)which could up-regulate DUSP1 (Tachado et al., 2005). In
this study, either siRNA-mediated knockdown of DUSP1 or inhibition of
theDUSP1 activity by a speciﬁc inhibitor enhances and prolongs thep38
MAPK activation and the induction of IL-6 and IL-8 in IBV-infected cells.
These observations imply that up-regulation of DUSP1 by IBV may be a
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and limit pro-inﬂammatory cytokine expression. The mechanisms
that control the IBV-mediated up-regulation of DUSP1 await elucida-
tion. One possibility is that some of the IBV proteinsmay be able to trig-
ger its activation. Alternatively, the virus may up-regulate DUSP1
indirectly by activation of either IL-1 or TNFα, as an increase in IL-1β
and TNFα production in IBV-infected cells was also observed (unpub-
lished observations). More systematic studies are underway to address
these issues further.
One of the protein kinases that activate the p38 MAPK pathway is
PKR (Goh et al., 2000), which is implicated as a modulator of signaling
pathways in response to cellular stresses. It is well known that this
cytoplasmic serine/threonine kinase phosphorylates the eukaryotic
initiation factor 2α (eIF2α) and inhibits translation (Dar et al.,
2005; Dey et al., 2005). A recent study reported that PKR-dependent
activation of MAPK is induced in vaccinia virus-infected cells, but is
antagonized by viral E3L protein (Zhang et al., 2009). In addition,
PKR is also involved in other signaling pathways, including p53,interferon regulatory factor 1 (IRF1) and nuclear factor κB (NFκB)
(Kumar et al., 1997; Lemaire et al., 2008).
Similar to that in cells infected with other RNA viruses, dsRNA is
generated as a replication intermediate in coronavirus-infected cells
during the replication and transcription of the genomic and subge-
nomic RNA by a discontinuous transcription mechanism (Sawicki et
al., 2007; Zuniga et al., 2004). PKR may act as a major sensor of cyto-
solic dsRNA (Sadler and Williams, 2007; Yang et al., 1995), and plays
a role in transduction of pro-inﬂammatory signals by mediating the
activation of dsRNA-dependent NFκB (Zamanian-Daryoush et al.,
2000). However, it remains unclear whether the PKR kinase activity is
directly required for signal transduction or PKR may simply function
as a structural protein via interaction with other kinases and adaptor
proteins. For instance, PKR was suggested to interact with TRAF6,
TAK1, and TAB2 as a scaffold protein to mediate TLR3-dependent
NF-κB and MAPK activation (Jiang et al., 2003). PKR was also linked
to TRAF2 and TRAF5 (Gil et al., 2004). A more recent study in human
keratinocytes proposed a central role for PKR in dsRNA-mediated type
114 Y. Liao et al. / Virology 420 (2011) 106–116I IFN responses involving both TLR3 and RIG-I pathways (Kalali et al.,
2008). Alternatively, PKRwas shown to activate the p38MAPKpathway
in response to dsRNA by phosphorylation of the upstream kinaseMKK6
(Silva et al., 2004). It would be interesting to investigate if PKR is active-
ly involved in IBV-induced p38MAPKactivation and IL-6/IL-8 induction.
As PKR phosphorylation was shown to be severely inhibited in IBV-
infected cells at later stages of the replication cycles (73), itmay suggest
that the kinase activity of PKR may be not critically required for its in-
volvement in the induction of IL-6 and IL-8.
Materials and methods
Cell culture and virus
Vero andHuh7 cells weremaintained in DMEMwith 4500 mg/l glu-
cose supplemented with 10% fetal bovine serum (FBS) (Hyclone, USA),
penicillin (100 units/ml) and streptomycin (100 μg/ml) (Invitrogen,
USA) at 37 °C in a 5% CO2 environment. H1299 cells were similarly
maintained using RPMI medium supplemented with 10% FBS in the
presence of penicillin and streptomycin. Vero cells were isolated from
kidney epithelial cells extracted from an African green monkey. Huh-7
is a well differentiated hepatocyte-derived cellular carcinoma cell line
that was originally taken from a liver tumor in a 57-year-old Japanese
male in 1982. H1299 is a human non-small cell lung carcinoma cell
line derived from the lymph node. Wild type mouse embryonic ﬁbro-
blast cells (MEFs) and themutant p38MAPK knock-inMEFsweremain-
tained in DMEMwith 10% FBS at 37 °C in a 5% CO2 incubator.
The egg-adapted Beaudette strain of IBV (ATCC VR-22) adapted to
Vero cells was used in this study (Ng and Liu, 1998). Virus stocks were
prepared by infection of Vero cells with 0.1 plaque-forming units (PFU)
of virus per cell and incubation at 37 °C for 24 h. After freezing and thaw-
ing for three times, cell debris was removed by centrifugation at
3000×rpm, and supernatants were aliquoted and stored at −80 °C as
virus stocks. Titers of the virus stocks were determined by plaque assay
on Vero cells, and virus was used for infection at multiplicity of infection
(MOI) of 1 throughout this study. Inactivation of IBV was performed by
exposing the virus preparation to 120,000 mJ/cm2 of 254-nm shortwave
ultraviolet (UV) radiation for 10 min within a CL-1000 cross-linker.
Reagents and antibodies
The p38MAPK inhibitor SB203580 and DUSP1 inhibitor Ro-31-8200
were purchased from Sigma-Aldrich (USA) and dissolved in DMSO.
Cells were either treated with 10 μM of Ro-31-8200 or 50 μM of
SB203580 or mock-treated with DMSO alone for 1 h prior to IBV infec-
tion and throughout the time-course.
Polyclonal IBV S, IBV N and IBVM antibodies were raised from rab-
bits against bacterially expressed fusion proteins (Li et al., 2005; Liao
et al., 2006). Antibodies against phosphor-MKK3/6 (p-MKK3/6) (cat-
alog no. 9231), MKK3 (catalog no. 9232), phosphor-p38 (p-p38) (cat-
alog no. 9211), p38 (catalog no. 9212) and β-tubulin (catalog no.
2128) were purchased from Cell Signaling Technology (USA), actin
antibody (catalog sc-1616) was purchased from Santa Cruz Biotech-
nology (USA), and the secondary IgG conjugated with HRP was
obtained from Dako.
Microarray hybridization and image analysis
Microarray hybridization and image analysis was carried out as
previously described (Nasirudeen and Liu, 2009). Brieﬂy, RNA was in-
dependently prepared from IBV-infected Vero cells harvested at 24 h
post-infection and hybridized to GeneChip® Human Genome U133A
Array (Affymetrix, USA) following the manufacturer's instructions
(Affymetrix). GeneChip arrays were scanned on an Affymetrix probe
array scanner. Data were preliminarily analyzed using the statistics
software Microarray Suite version 5.0 (MAS5.0) from Affymetrix.Total RNA extraction and semi-quantitative reverse transcription (RT)-
polymerase chain reaction (PCR)
Cells were lysed in Trizol® reagent (Invitrogen, USA) before a one-
ﬁfth volume of chloroform was added. The mixture was centrifuged
at 13,000×rpm for 15 min at 4 °C, and the aqueous phase was then
mixed with an equal volume of 100% isopropanol and incubated at
room temperature for 10 min. RNAwas precipitated by centrifugation
at 13,000×rpm for 10 min at 4 °C. RNA pellets were washed with 70%
RNase-free ethanol and dissolved in RNase-free water. 3 μg of total
RNA was used to perform reverse transcription using expand reverse
transcriptase (Roche, USA) and oligo-dT or speciﬁc primers. Equal
volume of cDNAs was then PCR-ampliﬁed using appropriate primers.
The primer pairs used in the PCR were: 5′-IL-6 (5′-AAATTCGGTA-
CATCCTCGAC GG-3′ forward) and 3′-IL-6 (TCTGGCTTGTTCCTCACTACT-
3′ reverse) for IL-6, 5′-IL-8 (5′-GTCAGTGCATAAAGACATACTCCA-3′ for-
ward) and 3′-IL-8 (5′-CTCAGCCCTCT TCAAAAACTTCTG-3′ reverse) for
IL-8, 5′-IRF1 (5′-GACCCTGGCTAGAG ATGCAGA-3′ forward) and 3′-IRF1
(5′-TTTCCCTTCCTCATCCTCATC-3′ reverse) for IRF1, 5′-IBV (5′-TTTAGCA-
GAACATTTTGACGCAGAT-3′ forward) and 3′-IBV (5′-TTAGTAGAA CCAA-
CAAACACGACAG-3′ reverse) for the positive strand IBV genomic RNA
(gRNA(+)), 5′-IBV (5′-TTAGTAGAACCAACAAACACGACAG-3′ forward)
and 3′-IBV (5′-TTTAGCAGAACATTTTGACGCAGAT-3′ reverse) for nega-
tive strand IBV RNA (gRNA(−)), 5′-GAPDH (5′-GGAGTCAACGGATTTG-
GTCG-3′ forward) and 3′-GAPDH (5′-TGCAAATGAGCCCCAGCCTT-3′
reverse) for GAPDH, 5′-p38 (5′-CAGCTTCAGCA GATTATGCGT-3′ for-
ward) and 3′-p38 (5′-GTACTGAGCAAAGTAGGCATGT-3′ reverse) for
p38 MAPK, 5′-DUSP1 (5′-AGAATGCTGG AGGAAGGGTGTTTG-3′ for-
ward) and 3′-DUSP1 (5′-GGTCGTAATGGGGCTCTGAAG GTA-3′ reverse)
for DUSP1.
Northern blot analysis
Probes were prepared by RT-PCR and labeledwith digoxigenin (DIG)
using the DIG labeling kit (Roche, USA). Brieﬂy, 3 μg of total RNA was
used to perform reverse transcription using expand reverse transcriptase
(Roche, USA), and cDNA was then subjected to PCR using appropriate
primers and digoxigenin(DIG) labeling kit. Primers used for preparation
of IL-6, IL-8, IRF1, IBV RNA, GAPDH and DUSP1 probes were the same as
the primers used for semi-quantitative RT-PCR.
For detection of a speciﬁc mRNA, an equal amount of total RNA was
denatured at 65 °C for 20 min before gel electrophoresis. RNAs were
transferred onto Hybond N+ membrane (GE Healthcare, USA) and
ﬁxed byUV crosslinking using Stratalinker (Stratagene, USA). DIG-labeled
speciﬁc DNA probes were denatured at 100 °C for 10 min and put on ice
immediately for 5 min before incubation with membranes at 42 °C over-
night. After washing for three times at 68 °C, membranes were incubated
with anti-DIG antibody for 1 h at room temperature, and the signals were
detected using CDP-Star chemiluminescence substrate (Roche) according
to themanufacturer's instructions and exposed to X-rayﬁlm (Fuji).Mem-
branes were stripped in 0.1% SDS in water by boiling at 100 °C for 10 min
before they were re-probed.
Western blot analysis
Cells were lysed with 1xSDS loading buffer in the presence of
100 mM dithiothreitol and denatured at 100 °C for 5 min before apply-
ing to SDA-PAGE. Proteins were transferred onto polyvinylidene diﬂuor-
ide (PVDF) membranes (Bio-Rad Laboratories, USA). After incubation
with blocking buffer (5% non-fat milk in PBST) for 1 h, the membranes
were incubated with appropriate antibodies in blocking buffer for 1 h
at room temperature. After washing thrice with PBST, membranes
were incubated with HRP-conjugated secondary antibody for 1 h and
washed three times with PBST. Blots were developed with an enhanced
chemiluminescence (ECL) detection system (Amersham Pharmacia,
USA) and exposed to X-ray ﬁlm (Fuji). Membranes were stripped in
115Y. Liao et al. / Virology 420 (2011) 106–116stripping buffer (10 mM β-mercapoethanol, 2% SDS, 62.5 mM Tris, pH
6.8) at 55 °C for 30 min before they were re-probed.
Transfection of siRNA
Cells were seeded on 6-well plate and grown to 40–50% conﬂuence
before transfection with siRNA. Transfection was carried out with Dhar-
mafect 2 (Dharmacon, USA) according to the manufacturer's standard
protocol (Dhamarcon), and was repeated 24 h after the ﬁrst transfection.
Cells were then infected with IBV at an MOI of approximately 1 at 24 h
after the second transfection and incubated for different time periods be-
fore lysis. The target sequence of p38 MAPK siRNA is 5′-GAACUGCG-
GUUACUUAAAC-3′. DUSP1 siRNA (sc-35937) was purchased from Santa
Cruz Biotechnology (USA), and the negative control (AM4635) was pur-
chased from Ambion (USA).
Densitometry
The intensities of corresponding bands were quantiﬁed using Ima-
geJ program according to manufacturer's instruction.
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